期刊文献+

不同指征介入性产前诊断的异常染色体检出率及其安全性分析 被引量:14

Detection rate of chromosomal abnormalities in women with different indications for invasive prenatal diagnosis and procedure-related complications
原文传递
导出
摘要 目的探讨不同指征介入性产前诊断(羊膜腔穿刺和脐血管穿刺)的异常染色体检出率以及介入性产前诊断技术的安全性。方法回顾性分析本中心1264例介入性产前诊断(1082例羊膜腔穿刺和182例脐血管穿刺)的手术指征、不同指征的异常染色体检出率及穿刺相关并发症。结果1264例介入性产前诊断中,穿刺指征分别为:血清学筛查高风险651例(5i.5%)、孕妇高龄(年龄≥35岁)318例(25.2%)、超声胎儿结构异常136例(10.8%)、不良妊娠史88例(6.9%)、血清学筛查一项或两项标志物MoM值异常52例(4.1%)和夫妇一方染色体平衡易位携带19例(1.5%)。共检出有临床意义的染色体异常37例,其穿刺指征依次为:超声提示胎儿结构异常20例(20/136,14.7%),血清学筛查高风险12例(12/651,1.8%),至少一项标志物MoM值异常1例(1/52,1.9%),不良妊娠史1例(1/88,1.1%),夫妇一方染色体平衡易位携带3例(3/19,15.8%),孕妇年龄≥35岁者未检出有临床意义的染色体异常(0/318)。1264例介入性产前诊断中共有5例自然流产,其中与羊膜腔穿刺相关的胎儿丢失率为0.28%(3/1082),与脐血管穿刺相关的胎儿丢失率为1.09%(2/182),两者相比差异无统计学意义(P=0.154)。脐血管穿刺后孕妇心慌、腹痛以及胎心减慢等并发症的发生率明显高于羊膜腔穿刺组(9.89%和0.18%,P=0.001)。结论超声发现胎儿结构异常应常规检查胎儿核型;单纯高龄作为介入性产前诊断的指征值得商榷;介入性产前诊断从安全性角度应首选羊膜腔穿刺术。 Objective To discuss the detection rate of chromosomal abnormalities in women with different indications for invasive prenatal diagnosis (amniocentesis and cordocentesis), and the procedure-related complications. Methods A retrospective analysis was conducted on 1264 women, who underwent invasive prenatal diagnosis (1082 amniocentesis and 182 cordocentesis), and the procedure-related complications were reviewed. Results The indications for invasive prenatal diagnosis in these 1264 women were: increased risk at prenatal screening (651, 51.5%), advanced maternal age ( ≥ 35) ( 318, 25.2%), abnormal foundings through ultrasonograph ( 136, 10.8%), history of adverse pregnancy(88,6.9%), one or two abnormal serologic markers(52,4.1%), and chromosomal balance translocation carrier in either one of the couple(19, 1.5 %). Thirty-seven cases were found to be chromosomal abnormalities with clinic significance and the indications for them were: ultrasonic abnormality (20/136, 14.7%); increased risk at prenatal screening (12/651, 1.8%); one or two abnormal serologic markers (1/52, 1.9%) ; history of adverse-pregnant (1/88, 1.1%) ; chromosomal balance translocation carrier in either one of the couple (3/19, 15.8%); advanced maternal age (0/318). Among the 1264 cases, 5 experienced spontaneous abortion and the procedurerelated fetal loss rates were 0.28% for amniocentesis (3/1082) and 1.09% for cordocentesis (2/182), P=0. 154. The rate of complications after cordocentesis was significantly higher than amniocentesis (9.89% vs 0. 18% ,P=0. 0001). Conclusions Routine fetal karyotyping should be prompted after prenatal ultrasonographic abnormalities. However, invasive prenatal diagnosis due to advanced maternal age alone is controversial. Amniocentesis is the fist choice for invasive prenatal diagnosis.
出处 《中华围产医学杂志》 CAS 2009年第2期88-92,共5页 Chinese Journal of Perinatal Medicine
基金 江苏省六大人才高峰资助项目(07-B-001) 江苏省科教兴卫工程重点学科母胎医学中心资助项目(XK200709) 江苏省医学分子生物学重点实验室课题(KL-002)
关键词 羊膜腔穿刺术 脐带穿刺术 产前诊断 染色体畸变 妊娠结局 Amniocentesis Cordocentesis Prenatal diagnosis Chromosome aberrations Pregnancy outcome
  • 相关文献

参考文献10

  • 1Bethune M.Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome:thickened nuchal fold,echogenic bowel,shortened femur,shortened humerus,pyelectasis and absent or hypoplastic nasal bone.Australas Radiol,2007,51:218-225.
  • 2Liao C,Huang Y,Li D,et al.Second-trimester maternal serum screening for Down syndrome in China's Mainland.Prenat Diagn,2006,26:1271-1272.
  • 3O'Leary P,Breheny N,Dickinson JE,et al.First-trimester combined screening for Down syndrome and other fetal anomalies.Obstet Gynecol,2006,107:869-876.
  • 4Cuckle HS,Malone FD,Wright D,et al.Contingent screening for Down syndrome-results from the FASTER trial.Prenat Diagn,2008,28:89-94.
  • 5ACOG Practice Bulletin.No.88.Invasive prenatal testing for aneuploidy.Obstet Gynecol,2007,110:1459-1467.
  • 6Eddleman KA,Malone FD,Sullivan L,et al Pregnancy loss rate after midtrimester amnicocentesis Obstet Gynecol,2006,108:1067-1072.
  • 7Mungen E,Tutuncu L,Muhcu M,et al.Pregnancy outcome following second-trimester amniocentesis:a case-control study.Am J Perinatol,2006,23:25-30.
  • 8Ghidini A,Sepulveda W,Lockwood CJ,et al.Complications of fetal blood sampling.Am J Obstet Gynecol,1993,168:1339-1344.
  • 9Petrikovsky B,Schneider EP,Klein VR,et al.Cordocentesis using the combined technique; needle guide-assisted and freehand.Fetal Diagn Ther,1997,12:252-254.
  • 10Tongsong T,Wanapirak C,Kunavikatikul C,et al.Cordocentesis at 16-24weeks of gestation:experience of 1320 cases.Prenat Diagn,2000,20:224-228.

同被引文献89

  • 1李艳.孕中期羊膜腔穿刺术的胎儿丢失率[J].中国产前诊断杂志(电子版),2010(4):44-47. 被引量:3
  • 2杨湘玲,朱健生,刘贤云.新型无创DNA产前检测在诊断胎儿染色体非整倍体疾病中的应用[J].中国产前诊断杂志(电子版),2013,5(2):15-17. 被引量:20
  • 3段程颖,偶健,刘一琳,傅文宇,孙健姜,东李红.孕中期羊水染色体细胞遗传学分析[J].中国产前诊断杂志(电子版),2013,5(2):22-25. 被引量:4
  • 4ACOG. Invasive prenatal testing for aneuploidy[J]. Obstet Gynecol, 2007,110(6) : 1459-1467.
  • 5Faris M, Zarko A. Procedure-related complications of amniocentesis and chorionic villous sampling a systematic review[J]. Obstetrics Gynecology, 2007,110(3) : 687-694.
  • 6Mazza V, Pati M, Bertueei E, et al. Age-specific risk of fetal loss post second trimester amniocentesis:analysis of 5043 cases [J]. Prenat Diagn, 2007,27 (2) : 180-183.
  • 7Liao C, Huang Y, Li D, et al. Second-trimester maternal serum screening for Down syndrome in China's Mainland[J]. Prenat Diagn,2006,26(13) : 1271-1272.
  • 8OtLeary P, Breheny N, Dickinson JR, et al. First-trimester combined screening for Down syndrome and other fetal anomalies[J]. Obstet Gynecol,2006,107(4) :869-876,.
  • 9Bethune M. Literature review and suggested protocol for managing ultrasound soft markers for Down syndromel thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus,pyelectasis and absent or hypoplastic nasal bone[J]. Australas Radiol, 2007,51 (3) : 218-225.
  • 10Cuckle HS,Malone FD,Wright D, et al. Contingent screening for Down syndrome-results from the FASTER trial[J]. Prenat Diagn, 2008,28(2) : 89-94.

引证文献14

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部